Your session is about to expire
← Back to Search
Telerehabilitation for Low Vision (BeST-AID Trial)
N/A
Recruiting
Led By Ava K Bittner, OD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 4 months
Awards & highlights
BeST-AID Trial Summary
This trial is testing whether providing remotely-delivered training to use magnification devices via videoconferencing is effective in enhancing visual function, compared to additional in-office training sessions.
Who is the study for?
This trial is for adults with any level of vision loss from ocular disease who have just received new magnification devices. It's not suitable for those with substance abuse, significant hearing loss, major health issues affecting lifespan or participation, scheduling conflicts during the study period, cognitive impairments that affect communication and understanding, or need other types of low vision rehabilitation training.Check my eligibility
What is being tested?
The trial is testing telerehabilitation—a way to train patients in using magnification devices via videoconferencing at home—against traditional in-office training. Participants will be randomly assigned to either home-based teletraining or additional office sessions after an initial office visit. The use of Bluetooth beacon sensors on devices will also be evaluated to monitor usage patterns.See study design
What are the potential side effects?
Since this intervention involves non-invasive training and monitoring methods rather than medication or surgery, there are no direct medical side effects expected. However, participants may experience frustration or difficulty adapting to the technology used.
BeST-AID Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 month, 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activity Inventory
Secondary outcome measures
Geriatric Depression Scale (GDS)
Hospital Anxiety & Depression Scale
MNread
+1 moreBeST-AID Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Telerehabilitation with low vision providerExperimental Treatment1 Intervention
Group II: Telerehabilitation w/ low vision provider plus tele-extenderExperimental Treatment1 Intervention
Group III: Usual Care (active control)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Vision Rehabilitation
2021
N/A
~150
Find a Location
Who is running the clinical trial?
Boston University Eye Associates, Inc. (study site)UNKNOWN
University of Nebraska Medical Center, Dept. of Ophthalmology (study site)UNKNOWN
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,731 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of using drugs or alcohol excessively.You have trouble hearing and cannot communicate using a phone or video calls.You need additional training or help with technology, computer skills, or emotional support.The magnifier device cannot work with the beacon sensors because it doesn't have a place for the patient's hand to hold it, and it doesn't have a flat surface where the sensor can be attached.You have vision loss from an eye disease and are 18 years or older.You have not previously received a new magnification device from one of our participating sites.People aged 18 and older who have received a new magnification device for the first time due to vision loss from an eye disease at one of our participating sites.
Research Study Groups:
This trial has the following groups:- Group 1: Telerehabilitation with low vision provider
- Group 2: Telerehabilitation w/ low vision provider plus tele-extender
- Group 3: Usual Care (active control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people have chosen to participate in the research project?
"This medical trial requires 120 patients that meet the outlined inclusion criteria. These individuals can register for this study at locations including The Eye Institute in San Francisco, New york and the New England College of Optometry in Boston, Massachusetts."
Answered by AI
Is this study actively seeking participants?
"Affirmative. The details posted on clinicaltrials.gov suggest that this medical research, initiated on October 1st 2019, is actively seeking out participants. A total of 120 people are required to be identified from 11 centres across the nation."
Answered by AI
How many venues can participants access this research trial?
"The scope of this clinical trial spans across the United States, with New England College of Optometry in Boston, Massachusetts and Southern Califonia College of Optometry in Fullerton, Michigan as well as 11 additional locations serving as its primary sites. Notably it is also being conducted at Frank Stein & Paul S. May Center for Low Vision Rehabilitation at The Eye Institute in San Francisco, New york."
Answered by AI
Who else is applying?
What site did they apply to?
Frank Stein & Paul S. May Center for Low Vision Rehabilitation at The Eye Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I’d like to learn more about low vision, as someone who has significant vision impairment, and wanted to join this trial in order to do so.
PatientReceived 2+ prior treatments
What questions have other patients asked about this trial?
How long do screening visits take? Who is the ideal candidate for this trial?
PatientReceived no prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger